IP Case Law › Patents › Societe Des Produits Nestle SA v. The Controller of Patents …
Relevant Acts and provisions
Patents Act, 1970
Section 2(1)(ja)Section 3(e)Section 3(i)Section 59
Provisions considered: Sections 3(e), 3(i) and 59 of the Patents Act, 1970, on the method-of-treatment exclusion, synergy and claim amendment.
Brief facts
Nestle's national phase application for a composition for prophylaxis of allergic disease was refused under Section 15 on the grounds that its claims fell within the method-of-treatment exclusion under Section 3(i), that a claim amendment made during prosecution impermissibly broadened the claims under Section 59, and that insufficient comparative data of synergistic effect was shown under Section 3(e).
Issues before the Court
- Does a composition claim limited to prophylactic use fall within the Section 3(i) exclusion for methods of treatment?
- Can the High Court permit an applicant, on appeal, to revert to an earlier claim abandoned only to meet an untenable objection?
Court's findings
The Court held that a composition claim drafted with reference to its therapeutic use is not thereby converted into a process of treatment within Section 3(i); the exclusion targets processes of treatment, not product or composition claims that are merely limited in purpose, so the Controller's Section 3(i) objection was untenable.
The Court held that since the claim amendment restricting the claims to a pure composition form had been made only to meet the unsustainable Section 3(i) objection, the appellant could properly revert to its earlier purpose-limited claim; the High Court in appeal has the same power as the Controller under Section 15 to permit amendment of claims, an appeal being a continuation of the original proceedings.
On synergy, the Court held that the appellant's data comparing the claimed composition against its individual components sufficiently demonstrated a synergistic effect, so the Section 3(e) objection could not be sustained, and it further found the invention satisfied the requirement of inventive step.
Decision
Appeal allowed; the refusal order was set aside and the application, on the appellant's reverted claims, was directed to proceed towards grant.
Key legal principle / ratio
An appellate court hearing a challenge to refusal of a patent application has the same power as the Controller under Section 15 to permit amendment of claims, an appeal being a continuation of the original proceedings; a composition claim limited to a therapeutic purpose is not a process of treatment excluded under Section 3(i), and an applicant may revert under Section 59 to an earlier claim abandoned only to meet an untenable objection.
Cases cited
- Nippon A&L Inc. v. The Controller of Patents, 2022 SCC OnLine Del 1909
Authorities referred to in the decision. Please verify each citation in the judgment itself.
Keywords
Claim Amendment Inventive Step Patent Prosecution Section 3(i) Section 59 Synergy
Read the judgment
More Patents judgments
Array Biopharma Inc v. Deputy Controller of Patents and Designs
A combination of distinct and independent active drugs, each with its own chemical identity and mechanism, does not fall under the Section 3(d) bar for derivatives of known substances. Using phrases such as 'for simultaneous, sepa…
Inventive StepMethod of TreatmentPharmaceutical CombinationPrior ArtPatentsBayer Corporation v. Union of India & Ors.
A compulsory licence under Section 84 of the Patents Act, 1970 may be granted where the reasonable requirements of the public with respect to a patented invention have not been satisfied, the invention is not available at a reason…
Compulsory LicencePublic HealthReasonably Affordable PriceSection 84PatentsBigtec Private Limited v. Assistant Controller of Patents and Designs
An objection that devising nucleotide probes or primers is routine experimentation lacking inventive step under Section 2(1)(ja) must engage with evidence of unexpected effects placed on record; and the Section 3(c) exclusion for …
BiotechnologyInventive StepPatent ProsecutionPrior Art